How social media can help to understand treatment experiences of survivors of rare cancers
Cancer specialists have taken a novel path to advance their research—tapping into a Facebook group for rare ovarian cancer insights.
Apr 6, 2023
0
31
MeSH tree: C12.050.351.500.056.630.705
Cancer specialists have taken a novel path to advance their research—tapping into a Facebook group for rare ovarian cancer insights.
Apr 6, 2023
0
31
US pharmaceutical giant Johnson & Johnson on Tuesday proposed an $8.9 billion settlement to resolve years-old lawsuits claiming that its talcum powder products caused cancer.
Apr 5, 2023
0
63
All hormonal contraceptives carry a slightly increased risk of breast cancer, including the increasingly popular progestogen-only pills, according to a study published on Tuesday.
Mar 25, 2023
0
236
A promising cancer drug that targets only cancer cells has been developed by researchers from the Norwegian University of Science and Technology (NTNU) and a university spin-off company, APIM Therapeutics.
Mar 22, 2023
0
147
New QIMR Berghofer research has found that low-dose aspirin may improve ovarian cancer survival.
Feb 7, 2023
1
119
Higher consumption of ultra-processed foods may be linked to an increased risk of developing and dying from cancer, an Imperial College London-led observational study suggests.
Jan 31, 2023
0
135
A genetic test developed in a study at the University of Helsinki and Helsinki University Hospital identifies ovarian cancer patients who benefit from PARP inhibitors, a treatment option.
Jan 11, 2023
0
64
The U.S. Food and Drug Administration (FDA) has approved the targeted imaging agent Cytalux (pafolacianine) for use in lung cancer surgery. This injectable diagnostic binds to cancerous tissue and glows when stimulated by ...
Dec 17, 2022
0
79
Some patients with prostate cancer have genetic mutations that may impact their treatment. A comprehensive, on-site genetic testing program, pioneered by urologists, could help to close the gap for this underutilized resource, ...
Dec 14, 2022
0
45
Mutations of BRCA1 and BRCA2 genes, which are inherited by 1 in 400 and 1 in 800 people respectively, significantly increase the risk of certain cancers such as ovarian, breast, pancreatic and prostate cancer.
Nov 28, 2022
0
55